Hyster-Yale Restructures — But 2026 Earnings Remain in the Red

Forward-Looking Analysis

Wall Street analysts project a challenging fiscal year 2026 for Hyster-Yale, with consensus estimates forecasting revenue of approximately $3.53 billion, representing a 6.32% year-over-year decline. Earnings per share (EPS) are expected to remain negative for the current year, with an average analyst estimate of -$2.83, although some data sources cite a slightly lower loss estimate of -$2.75. For 2027, sentiment shifts positively, with EPS forecast to turn profitable at an average of $2.07 to $2.13, driven by anticipated revenue growth of 9.07% to $3.85 billion.

Analyst coverage is sparse, with only two analysts providing estimates for the upcoming quarter. However, recent revisions show modest optimism for Q3 2026, where EPS estimates have been upgraded from -$0.13 to $0.11 over the last 30 days. The consensus price target stands at $45.00, implying roughly 34% upside from current levels, supported by a "Hold" rating. Despite the negative earnings outlook for 2026, long-term forecasts suggest a recovery, with ROE expected to reach 20.98% and revenue growth stabilizing at 6.57% annually through 2028. The primary near-term headwinds remain cyclical demand weakness and tariff pressures, which have contributed to a 12.7% revenue drop in Q1.

Historical Performance Review

Hyster-Yale’s Q1 2026 results reflected significant cyclical headwinds, with consolidated revenues falling 12.7% year-over-year to $795.2 million, missing analyst estimates of $878.1 million. The company reported a net loss of $30.3 million and an adjusted EPS of -$1.64, which notably beat consensus estimates by 8.9%. Gross profit contracted to $124.8 million, resulting in a gross margin of 15.7%, down 3.8 percentage points from the prior year. Operating margin turned negative at -3.5%, compared to 2.3% in Q1 2025, driven by higher input costs and reduced efficiency. Despite the revenue miss, free cash flow improved to a burn of $32.9 million, down from $47 million in the previous quarter, signaling some operational stabilization despite the broader market downturn.

Additional News

In May 2026, Hyster-Yale declared a quarterly dividend increase to 36.5 cents per share, up from 36 cents, payable on both Class A and Class B shares. This follows a Q1 2026 report highlighting a 7% sequential increase in bookings, signaling early stabilization after the cyclical low in Q3 2025. Prior to this, in November 2025, the company announced a restructuring plan to reduce its global workforce by approximately 575 employees. This action was designed to align cost structures with lower industry volumes and is expected to generate $40 to $45 million in annualized cost savings beginning in Q1 2026. The restructuring aims to reduce the break-even point, positioning the company for enhanced profitability when demand recovers, likely in mid-2026. These cost reduction efforts are additive to previous initiatives and are intended to optimize overhead and operational efficiency amidst challenging market conditions and tariff uncertainties.

Summary & Outlook

Hyster-Yale faces near-term financial strain with negative earnings and declining revenues, yet maintains a moderate dividend yield of 4.25%. The primary risk stems from cyclical demand weakness and tariff impacts, which pressured Q1 margins. However, growth catalysts include a 7% sequential booking increase in Q1 and $40-$45 million in annualized savings from recent restructuring. Analysts anticipate a turnaround in 2027 with positive EPS and revenue growth. While near-term prospects are neutral due to execution risks and macro headwinds, the strategic cost-cutting measures and improving booking trends suggest a cautiously optimistic long-term outlook. The stock remains a hold, with valuation metrics reflecting current uncertainty rather than fundamental collapse.